Keywords

Oral immunotherapy, food allergies, preschoolers, allergy research, immunology, safety, treatment, public health, pediatric allergies, clinical practice

Summary

This podcast episode features Dr. Lianne Soller discussing the significance of oral immunotherapy (OIT) in preschoolers, emphasising its safety, the importance of early intervention, and the need for a shift in public health messaging regarding food allergies. The conversation explores the unique characteristics of preschoolers' immune systems that make them more responsive to treatment, practical applications of OIT in various healthcare settings, and the potential for OIT to become a standard approach in managing food allergies.

Takeaways

• Oral immunotherapy (OIT) is crucial for preschoolers.
• Starting OIT early prevents food aversion in children.
• Preschoolers' immune systems are more adaptable to treatment.
• OIT is safer for younger children than previously thought.
• Healthcare providers should reassure families about OIT safety.
• Telehealth can facilitate access to OIT for remote families.
• OIT protocols can be adjusted for individual patient needs.
• Public health messaging needs to evolve regarding food allergies.
• Shared decision-making is essential in allergy management.
• Normalising the introduction of allergens is important for children.

Keywords

Allergy, lipid transfer protein, food allergy, pollen food syndrome, diagnosis, management, diet, adrenaline, co-factors, clinical research

Summary

In this episode of the Clinical and Experimental Allergy podcast, hosts Mo Shamji and Robert Boyle engage with Dr. Isabel Skypala, a consultant allergy dietician, to discuss the increasing recognition of lipid transfer protein (LTP) allergy in the UK. Dr. Skypala shares insights into the challenges of diagnosing LTP allergy, particularly due to its overlap with pollen food syndrome, and emphasizes the importance of a thorough clinical history. The conversation also covers management strategies for patients with LTP allergy, including the role of co-factors, the creation of safe diets, and considerations for the use of adrenaline auto-injectors. Dr. Skypala highlights the need for individualized approaches in allergy management, ensuring that patients can maintain a balanced diet while avoiding triggers.

Takeaways

• LTP allergy is increasingly recognized in the UK.
• Diagnosis requires careful clinical history taking.
• Symptoms of LTP allergy can vary significantly.
• Cofactors like exercise and alcohol can trigger reactions.
• Individualized dietary plans are essential for patients.
• Food challenges can help identify safe foods.
• Different varieties of fruits may be tolerated differently.
• Adrenaline auto-injectors may be necessary for high-risk patients.
• Management strategies must consider lifestyle factors.
• Collaboration among clinicians is vital for effective allergy management.

Chapters

00:00 Introduction to the speakers

01:17 Understanding Lipid Transfer Protein Allergy

02:54 Challenges in Diagnosing LTP Allergy

04:22 Management Strategies for LTP Allergy with co-factors

05:32 Dietary Considerations and Food Challenges

07:21 Adrenaline Auto-Injectors and Risk Assessment

08:41 Closing the podcast

Keywords

Chronic cough, TRP receptors, P2X3 receptors, neuroplasticity, allergy, immunology, ATP release, bronchial epithelial cells, therapeutic approaches, research

Summary:

In this episode of the Clinical and Experimental Allergy podcast, Dr. Jonathan Bernstein discusses his research on chronic cough, focusing on the role of TRP receptors and P2X3 receptors in understanding the mechanisms behind this condition. He shares insights from his in vitro studies, unexpected findings related to chronic cough pathways, and potential future therapeutic approaches targeting these receptors.

Takeaways

• Dr. Bernstein is a professor of medicine at the University of Cincinnati.
• His research focuses on chronic cough and its underlying mechanisms.
• In vitro assays help isolate different cell activation pathways.
• ATP release is critical for activating P2X3 receptors on bronchial epithelial cells.
• Unexpected pathways activated by ATP include FAC signaling and IL-4.
• P2X3 antagonists can down-regulate pathways promoting airway inflammation.
• TRP receptors are the first interface between the body and the environment.
• Nonspecific triggers can activate TRP receptors, leading to increased ATP release.
• Selective antagonists for TRP receptors are still lacking.
• The nervous system plays a critical role in cough reflex mechanisms.